Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 8058045 Pyrazin-2-yl-pyridin-2-yl-amine and pyrazin-2-yl-pyrimidin-4-yl-amine compounds and their use

Patent 8058045 was granted and assigned to Cancer Research Technology Limited on November, 2011 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
‌
Cancer Research Technology Limited
0
Date Filed
October 6, 2008
0
Date of Patent
November 15, 2011
0
Patent Application Number
12680891
0
Patent Citations Received
‌
US Patent 11787792 5-[[4-[[morpholin-2-yl]methylamino]-5-(trifluoromethyl)-2 Pyridyl]Amino]Pyrazine-2-carbonitrile and therapeutic uses thereof
‌
US Patent 11945798 Substituted aminopyridine compounds as EGFR inhibitors
0
‌
US Patent 12006332 Aminopyrimidine derivatives as phosphatidylinositol phosphate kinase inhibitors
0
‌
US Patent 11981658 Substituted aminopyridine compounds as EGFR inhibitors
0
‌
US Patent 11667651 Aminopyridine derivatives as phosphatidylinositol phosphate kinase inhibitors
0
Patent Inventor Names
Thomas Peter Matthews
0
Jane Elizabeth Scanlon
0
David Hugh Williams
0
Glynn Jonathan Addison
0
Ian Collins
0
John Charles Reader
0
Kwai Ming Cheung
0
Michael Cherry
0
Nelly Piton
0
Nicolas Proisy
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
8058045
0
Patent Primary Examiner
‌
Sun Jae Loewe
0

Find more entities like US Patent 8058045 Pyrazin-2-yl-pyridin-2-yl-amine and pyrazin-2-yl-pyrimidin-4-yl-amine compounds and their use

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo